2021 Annual Meeting | S21 - Neuroepidemiology
Program Materials Program Evaluations
| 02:00 PM - 02:08 PM EDT | Abstract |
001 - Effect Of Linoleic Acid On Ischemic Stroke: A Mendelian Randomization Study.
David Wu |
| 02:08 PM - 02:16 PM EDT | Abstract |
002 - Midlife Cardiac Structure And Function Are Associated With Lower Midlife Cognition: the CARDIA Study
Laure Rouch |
| 02:16 PM - 02:24 PM EDT | Q&A |
Questions and Answers
|
| 02:24 PM - 02:32 PM EDT | Abstract |
003 - Anomalously warm weather and acute care visits in patients with multiple sclerosis: A retrospective study of privately insured individuals in the U.S.
Holly Elser, MD, PhD |
| 02:32 PM - 02:40 PM EDT | Abstract |
004 - COVID-19 outcomes in hospitalized patients with pre-existing neurodegenerative diseases in Chicagoland area
Roshni A. Patel, MD |
| 02:40 PM - 02:48 PM EDT | Abstract |
005 - Persistent Chemosensory Dysfunction Associated with COVID-19 Infection in a Cohort of over 800 Healthcare Workers
Nicholas Bussiere |
| 02:48 PM - 03:00 PM EDT | Q&A |
Questions and Answers
|
| No disclosure on file | |
| Holly Elser, MD, PhD | Dr. Elser has nothing to disclose. |
| Victor W. Henderson, MD, FAAN | Dr. Henderson has stock in Abbott, Amgen, Roche. The institution of Dr. Henderson has received research support from NIH. The institution of Dr. Henderson has received research support from Health IQ. Dr. Henderson has received personal compensation in the range of $500-$4,999 for serving as a External advisory committee member, Alzheimer's Disease Center with University of Kansas. Dr. Henderson has a non-compensated relationship as a adjunct (honorary) professor with Aarhus University that is relevant to AAN interests or activities. |
| Nicholas Bussiere | Mr. Bussiere has received research support from Fondation de l'UQTR. |
| Glenn T. Stebbins, PhD | Dr. Stebbins has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Biogen. Dr. Stebbins has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Partners Healthcare System. Dr. Stebbins has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for CHDI. The institution of Dr. Stebbins has received research support from Department of Defense. Dr. Stebbins has received research support from Cleveland Clinic Health Systems. Dr. Stebbins has received personal compensation in the range of $500-$4,999 for serving as a Course Director with MDS. |
| Nuriel Moghavem, MD | Dr. Moghavem has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Multiple Sclerosis Association of America. Dr. Moghavem has a non-compensated relationship as a Committee Member with National Multiple Sclerosis Society that is relevant to AAN interests or activities. Dr. Moghavem has a non-compensated relationship as a Board Member with Los Angeles County Medical Association that is relevant to AAN interests or activities. |
| Mathieu Blais | No disclosure on file |
| Nicolas Dupre, MD, FAAN | Dr. Dupre has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Akcea Therapeutics Canada. The institution of Dr. Dupre has received research support from ARSACS Foundation. The institution of Dr. Dupre has received research support from CHUdeQuebec Foundation. |
| Brandon Barton, MD, FAAN | Dr. Barton has nothing to disclose. |
| David Wu | Mr. Wu has nothing to disclose. |
| Roshni A. Patel, MD | Dr. Patel has nothing to disclose. |
| Stephen Sidney, MD, MPH | Dr. Sidney has nothing to disclose. |
| Laure Rouch | Laure Rouch has nothing to disclose. |
| Nina Bozinov, MD | Dr. Bozinov has nothing to disclose. |
| Kristine Yaffe, MD | Dr. Yaffe has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Lilly. Dr. Yaffe has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Quintiles. Dr. Yaffe has received personal compensation in the range of $10,000-$49,999 for serving as an officer or member of the Board of Directors for Alector. The institution of Dr. Yaffe has received research support from NIH. The institution of Dr. Yaffe has received research support from DOD. The institution of Dr. Yaffe has received research support from Veterans Affairs. |
| Deanna Saylor, MD, MHS | The institution of Dr. Saylor has received research support from National Institutes of Health. The institution of Dr. Saylor has received research support from National Multiple Sclerosis Society. The institution of Dr. Saylor has received research support from American Academy of Neurology. The institution of Dr. Saylor has received research support from United States Department of State. Dr. Saylor has a non-compensated relationship as a Member of multiple committees and task forces focused on improving access to MS medications to people across the world with Multiple Sclerosis International Federation that is relevant to AAN interests or activities. Dr. Saylor has a non-compensated relationship as a Member of the Neurology and COVID19 committee with World Health Organization that is relevant to AAN interests or activities. Dr. Saylor has a non-compensated relationship as a Member of the International Outreach Committee, Junior and Early Career Membership Committee, and Educational Innovation Commitees with American Neurological Association that is relevant to AAN interests or activities. |
| Altaf Saadi, MD, MSc, FAAN | The institution of Dr. Saadi has received research support from American Academy of Neurology. The institution of Dr. Saadi has received research support from National Science Foundation. The institution of Dr. Saadi has received research support from Russel Sage Foundation. The institution of Dr. Saadi has received research support from National Institute of Health. |